<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-8035 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-8035</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-8035</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-148.html">extraction-schema-148</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of neuronal populations within the visual (occipital) cortex that show selective vulnerability or resistance to amyloid‑β plaques or tau tangles in dementia, including details on cell type, cortical layer, subregion, pathology type, reported mechanisms, experimental models, quantitative measures, species, disease stage, and any contrasting findings.</div>
                <p><strong>Paper ID:</strong> paper-16817589</p>
                <p><strong>Paper Title:</strong> Understanding the Pathophysiology of Alzheimer's Disease and Mild Cognitive Impairment: A Mini Review on fMRI and ERP Studies</p>
                <p><strong>Paper Abstract:</strong> The prevalence of Alzheimer's disease (AD) is predicted to increase rapidly in the coming decade, highlighting the importance of early detection and intervention in patients with AD and mild cognitive impairment (MCI). Recently, remarkable advances have been made in the application of neuroimaging techniques in investigations of AD and MCI. Among the various neuroimaging techniques, functional magnetic resonance imaging (fMRI) has many potential advantages, noninvasively detecting alterations in brain function that may be present very early in the course of AD and MCI. In this paper, we first review task-related and resting-state fMRI studies on AD and MCI. We then present our recent fMRI studies with additional event-related potential (ERP) experiments during a motion perception task in MCI. Our results indicate that fMRI, especially when combined with ERP recording, can be useful for detecting spatiotemporal functional changes in AD and MCI patients.</p>
                <p><strong>Cost:</strong> 0.015</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e8035.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e8035.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of neuronal populations within the visual (occipital) cortex that show selective vulnerability or resistance to amyloid‑β plaques or tau tangles in dementia, including details on cell type, cortical layer, subregion, pathology type, reported mechanisms, experimental models, quantitative measures, species, disease stage, and any contrasting findings.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Vulnerable visual pyramidal neurons</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>A vulnerable subset of pyramidal neurons in primary and secondary visual cortex</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Review-cited reports identify a subset of pyramidal neurons in primary (V1) and secondary (V2) visual cortex as selectively vulnerable in Alzheimer's disease based on quantitative postmortem analyses.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>neuronal_population</strong></td>
                            <td>a vulnerable subset of pyramidal neurons</td>
                        </tr>
                        <tr>
                            <td><strong>cortical_subregion</strong></td>
                            <td>primary visual cortex (V1) and secondary visual cortex (V2)</td>
                        </tr>
                        <tr>
                            <td><strong>cortical_layer</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>vulnerability_status</strong></td>
                            <td>vulnerable</td>
                        </tr>
                        <tr>
                            <td><strong>pathology_type</strong></td>
                            <td>AD-related neuropathology (unspecified in-review; likely associated with neurofibrillary tangle pathology)</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_source</strong></td>
                            <td>human postmortem (quantitative neuropathology studies cited)</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_method</strong></td>
                            <td>quantitative morphological / histopathological analysis (as cited in review)</td>
                        </tr>
                        <tr>
                            <td><strong>quantitative_measure</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>reported_mechanism</strong></td>
                            <td>Not specified in this review; implicated as selectively affected within AD neuropathology (review implies association with neurodegenerative changes rather than a specific molecular mechanism).</td>
                        </tr>
                        <tr>
                            <td><strong>associated_genes_proteins</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>species</strong></td>
                            <td>Homo sapiens</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Alzheimer's disease (typical AD; stage not specified)</td>
                        </tr>
                        <tr>
                            <td><strong>counter_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>reference_citation</strong></td>
                            <td>Hof PR & Morrison JH, J Comp Neurol, 1990</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e8035.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e8035.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of neuronal populations within the visual (occipital) cortex that show selective vulnerability or resistance to amyloid‑β plaques or tau tangles in dementia, including details on cell type, cortical layer, subregion, pathology type, reported mechanisms, experimental models, quantitative measures, species, disease stage, and any contrasting findings.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Visual association area NFTs</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Neurofibrillary tangles concentrated in visual association (extrastriate) cortex</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The review states that neurofibrillary tangles (tau pathology) are preferentially found in visual association areas (extrastriate cortex) in typical Alzheimer's disease based on cited quantitative studies.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>neuronal_population</strong></td>
                            <td>neurons in visual association (extrastriate) cortex (cell types not further specified in the review)</td>
                        </tr>
                        <tr>
                            <td><strong>cortical_subregion</strong></td>
                            <td>visual association cortex / extrastriate visual areas</td>
                        </tr>
                        <tr>
                            <td><strong>cortical_layer</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>vulnerability_status</strong></td>
                            <td>vulnerable</td>
                        </tr>
                        <tr>
                            <td><strong>pathology_type</strong></td>
                            <td>tau tangles (neurofibrillary tangles)</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_source</strong></td>
                            <td>human postmortem (quantitative neuropathology studies cited)</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_method</strong></td>
                            <td>quantitative histopathology / laminar distribution analysis (as cited in review)</td>
                        </tr>
                        <tr>
                            <td><strong>quantitative_measure</strong></td>
                            <td>laminar and regional distributions reported (quantitative data reported in the cited study, but no numeric values given in this review)</td>
                        </tr>
                        <tr>
                            <td><strong>reported_mechanism</strong></td>
                            <td>Not specified in this review (no molecular mechanism described here linking selective NFT deposition to cell vulnerability).</td>
                        </tr>
                        <tr>
                            <td><strong>associated_genes_proteins</strong></td>
                            <td>tau (neurofibrillary tangle protein) implied</td>
                        </tr>
                        <tr>
                            <td><strong>species</strong></td>
                            <td>Homo sapiens</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Alzheimer's disease (typical AD; stage not specified)</td>
                        </tr>
                        <tr>
                            <td><strong>counter_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>reference_citation</strong></td>
                            <td>Lewis DA et al., The Journal of Neuroscience, 1987</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e8035.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e8035.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of neuronal populations within the visual (occipital) cortex that show selective vulnerability or resistance to amyloid‑β plaques or tau tangles in dementia, including details on cell type, cortical layer, subregion, pathology type, reported mechanisms, experimental models, quantitative measures, species, disease stage, and any contrasting findings.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Amyloid in visual cortex</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Amyloid‑β plaque distribution across primary and association visual areas</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The review cites studies reporting that amyloid-β plaques are reported to be more uniformly distributed across both primary (V1) and association visual areas in typical Alzheimer's disease, implying a lack of strong regional selectivity for plaques in visual cortex.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>neuronal_population</strong></td>
                            <td>broad populations of visual cortical neurons (no specific neuronal subtype identified as selectively spared or targeted by plaques in the review)</td>
                        </tr>
                        <tr>
                            <td><strong>cortical_subregion</strong></td>
                            <td>primary visual cortex (V1) and association visual areas (extrastriate)</td>
                        </tr>
                        <tr>
                            <td><strong>cortical_layer</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>vulnerability_status</strong></td>
                            <td>mixed</td>
                        </tr>
                        <tr>
                            <td><strong>pathology_type</strong></td>
                            <td>amyloid‑β plaques</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_source</strong></td>
                            <td>human postmortem (quantitative morphological studies cited)</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_method</strong></td>
                            <td>quantitative morphology / histopathology of plaque distribution (as cited)</td>
                        </tr>
                        <tr>
                            <td><strong>quantitative_measure</strong></td>
                            <td>described as 'uniformly distributed' across primary and association visual areas in the cited literature (no numeric plaque densities provided in this review)</td>
                        </tr>
                        <tr>
                            <td><strong>reported_mechanism</strong></td>
                            <td>Not specified; review notes distributional pattern but does not provide a mechanism for uniform plaque deposition across visual areas.</td>
                        </tr>
                        <tr>
                            <td><strong>associated_genes_proteins</strong></td>
                            <td>amyloid‑β (Aβ) implied</td>
                        </tr>
                        <tr>
                            <td><strong>species</strong></td>
                            <td>Homo sapiens</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Alzheimer's disease (typical AD; stage not specified)</td>
                        </tr>
                        <tr>
                            <td><strong>counter_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>reference_citation</strong></td>
                            <td>Rogers J & Morrison JH, The Journal of Neuroscience, 1985</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e8035.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e8035.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of neuronal populations within the visual (occipital) cortex that show selective vulnerability or resistance to amyloid‑β plaques or tau tangles in dementia, including details on cell type, cortical layer, subregion, pathology type, reported mechanisms, experimental models, quantitative measures, species, disease stage, and any contrasting findings.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Loss of long-range visual projections</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Loss of long corticocortical projections from early visual areas to V5 (dorsal pathway projection neurons)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The review cites anatomical/neuropathological work reporting a significant loss of long corticocortical projections from early visual areas to motion area V5/MT, suggesting selective vulnerability of long-range projection neurons in the dorsal visual pathway in AD.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>neuronal_population</strong></td>
                            <td>long corticocortical projection neurons from early visual areas projecting to V5/MT (presumed pyramidal projection cells)</td>
                        </tr>
                        <tr>
                            <td><strong>cortical_subregion</strong></td>
                            <td>early visual areas (V1/V2) → V5/MT (dorsal visual stream)</td>
                        </tr>
                        <tr>
                            <td><strong>cortical_layer</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>vulnerability_status</strong></td>
                            <td>vulnerable</td>
                        </tr>
                        <tr>
                            <td><strong>pathology_type</strong></td>
                            <td>AD-related structural/degenerative changes (not explicitly separated into plaques vs tangles in the review text)</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_source</strong></td>
                            <td>human anatomical / postmortem studies (as cited)</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_method</strong></td>
                            <td>anatomical / histopathological analysis of corticocortical projections (as cited in review)</td>
                        </tr>
                        <tr>
                            <td><strong>quantitative_measure</strong></td>
                            <td>reported as 'significant loss' of long corticocortical projections (no numeric values provided in this review)</td>
                        </tr>
                        <tr>
                            <td><strong>reported_mechanism</strong></td>
                            <td>Review suggests that loss of long-range projections may underlie dorsal-pathway susceptibility to AD-related neuropathology; specific cellular/molecular mechanisms not described here.</td>
                        </tr>
                        <tr>
                            <td><strong>associated_genes_proteins</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>species</strong></td>
                            <td>Homo sapiens</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Alzheimer's disease (typical AD; stage not specified)</td>
                        </tr>
                        <tr>
                            <td><strong>counter_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>reference_citation</strong></td>
                            <td>Pearson RC et al., Proceedings of the National Academy of Sciences, 1985</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease. <em>(Rating: 2)</em></li>
                <li>Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. <em>(Rating: 2)</em></li>
                <li>Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex. <em>(Rating: 2)</em></li>
                <li>Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. <em>(Rating: 2)</em></li>
                <li>The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. <em>(Rating: 1)</em></li>
            </ol>
        </div>

        <div class="section">
            <h2>Extracted Data (Debug)</h2>
            <pre><code>{
    "id": "extraction-result-8035",
    "paper_id": "paper-16817589",
    "extraction_schema_id": "extraction-schema-148",
    "extracted_data": [
        {
            "name_short": "Vulnerable visual pyramidal neurons",
            "name_full": "A vulnerable subset of pyramidal neurons in primary and secondary visual cortex",
            "brief_description": "Review-cited reports identify a subset of pyramidal neurons in primary (V1) and secondary (V2) visual cortex as selectively vulnerable in Alzheimer's disease based on quantitative postmortem analyses.",
            "citation_title": "Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex.",
            "mention_or_use": "mention",
            "neuronal_population": "a vulnerable subset of pyramidal neurons",
            "cortical_subregion": "primary visual cortex (V1) and secondary visual cortex (V2)",
            "cortical_layer": null,
            "vulnerability_status": "vulnerable",
            "pathology_type": "AD-related neuropathology (unspecified in-review; likely associated with neurofibrillary tangle pathology)",
            "evidence_source": "human postmortem (quantitative neuropathology studies cited)",
            "experimental_method": "quantitative morphological / histopathological analysis (as cited in review)",
            "quantitative_measure": null,
            "reported_mechanism": "Not specified in this review; implicated as selectively affected within AD neuropathology (review implies association with neurodegenerative changes rather than a specific molecular mechanism).",
            "associated_genes_proteins": null,
            "species": "Homo sapiens",
            "disease_stage": "Alzheimer's disease (typical AD; stage not specified)",
            "counter_evidence": null,
            "reference_citation": "Hof PR & Morrison JH, J Comp Neurol, 1990",
            "uuid": "e8035.0"
        },
        {
            "name_short": "Visual association area NFTs",
            "name_full": "Neurofibrillary tangles concentrated in visual association (extrastriate) cortex",
            "brief_description": "The review states that neurofibrillary tangles (tau pathology) are preferentially found in visual association areas (extrastriate cortex) in typical Alzheimer's disease based on cited quantitative studies.",
            "citation_title": "Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices.",
            "mention_or_use": "mention",
            "neuronal_population": "neurons in visual association (extrastriate) cortex (cell types not further specified in the review)",
            "cortical_subregion": "visual association cortex / extrastriate visual areas",
            "cortical_layer": null,
            "vulnerability_status": "vulnerable",
            "pathology_type": "tau tangles (neurofibrillary tangles)",
            "evidence_source": "human postmortem (quantitative neuropathology studies cited)",
            "experimental_method": "quantitative histopathology / laminar distribution analysis (as cited in review)",
            "quantitative_measure": "laminar and regional distributions reported (quantitative data reported in the cited study, but no numeric values given in this review)",
            "reported_mechanism": "Not specified in this review (no molecular mechanism described here linking selective NFT deposition to cell vulnerability).",
            "associated_genes_proteins": "tau (neurofibrillary tangle protein) implied",
            "species": "Homo sapiens",
            "disease_stage": "Alzheimer's disease (typical AD; stage not specified)",
            "counter_evidence": null,
            "reference_citation": "Lewis DA et al., The Journal of Neuroscience, 1987",
            "uuid": "e8035.1"
        },
        {
            "name_short": "Amyloid in visual cortex",
            "name_full": "Amyloid‑β plaque distribution across primary and association visual areas",
            "brief_description": "The review cites studies reporting that amyloid-β plaques are reported to be more uniformly distributed across both primary (V1) and association visual areas in typical Alzheimer's disease, implying a lack of strong regional selectivity for plaques in visual cortex.",
            "citation_title": "Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease.",
            "mention_or_use": "mention",
            "neuronal_population": "broad populations of visual cortical neurons (no specific neuronal subtype identified as selectively spared or targeted by plaques in the review)",
            "cortical_subregion": "primary visual cortex (V1) and association visual areas (extrastriate)",
            "cortical_layer": null,
            "vulnerability_status": "mixed",
            "pathology_type": "amyloid‑β plaques",
            "evidence_source": "human postmortem (quantitative morphological studies cited)",
            "experimental_method": "quantitative morphology / histopathology of plaque distribution (as cited)",
            "quantitative_measure": "described as 'uniformly distributed' across primary and association visual areas in the cited literature (no numeric plaque densities provided in this review)",
            "reported_mechanism": "Not specified; review notes distributional pattern but does not provide a mechanism for uniform plaque deposition across visual areas.",
            "associated_genes_proteins": "amyloid‑β (Aβ) implied",
            "species": "Homo sapiens",
            "disease_stage": "Alzheimer's disease (typical AD; stage not specified)",
            "counter_evidence": null,
            "reference_citation": "Rogers J & Morrison JH, The Journal of Neuroscience, 1985",
            "uuid": "e8035.2"
        },
        {
            "name_short": "Loss of long-range visual projections",
            "name_full": "Loss of long corticocortical projections from early visual areas to V5 (dorsal pathway projection neurons)",
            "brief_description": "The review cites anatomical/neuropathological work reporting a significant loss of long corticocortical projections from early visual areas to motion area V5/MT, suggesting selective vulnerability of long-range projection neurons in the dorsal visual pathway in AD.",
            "citation_title": "Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease.",
            "mention_or_use": "mention",
            "neuronal_population": "long corticocortical projection neurons from early visual areas projecting to V5/MT (presumed pyramidal projection cells)",
            "cortical_subregion": "early visual areas (V1/V2) → V5/MT (dorsal visual stream)",
            "cortical_layer": null,
            "vulnerability_status": "vulnerable",
            "pathology_type": "AD-related structural/degenerative changes (not explicitly separated into plaques vs tangles in the review text)",
            "evidence_source": "human anatomical / postmortem studies (as cited)",
            "experimental_method": "anatomical / histopathological analysis of corticocortical projections (as cited in review)",
            "quantitative_measure": "reported as 'significant loss' of long corticocortical projections (no numeric values provided in this review)",
            "reported_mechanism": "Review suggests that loss of long-range projections may underlie dorsal-pathway susceptibility to AD-related neuropathology; specific cellular/molecular mechanisms not described here.",
            "associated_genes_proteins": null,
            "species": "Homo sapiens",
            "disease_stage": "Alzheimer's disease (typical AD; stage not specified)",
            "counter_evidence": null,
            "reference_citation": "Pearson RC et al., Proceedings of the National Academy of Sciences, 1985",
            "uuid": "e8035.3"
        }
    ],
    "potentially_relevant_new_papers": [
        {
            "paper_title": "Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease.",
            "rating": 2,
            "sanitized_title": "quantitative_morphology_and_regional_and_laminar_distributions_of_senile_plaques_in_alzheimers_disease"
        },
        {
            "paper_title": "Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices.",
            "rating": 2,
            "sanitized_title": "laminar_and_regional_distributions_of_neurofibrillary_tangles_and_neuritic_plaques_in_alzheimers_disease_a_quantitative_study_of_visual_and_auditory_cortices"
        },
        {
            "paper_title": "Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex.",
            "rating": 2,
            "sanitized_title": "quantitative_analysis_of_a_vulnerable_subset_of_pyramidal_neurons_in_alzheimers_disease_ii_primary_and_secondary_visual_cortex"
        },
        {
            "paper_title": "Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease.",
            "rating": 2,
            "sanitized_title": "anatomical_correlates_of_the_distribution_of_the_pathological_changes_in_the_neocortex_in_alzheimers_disease"
        },
        {
            "paper_title": "The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease.",
            "rating": 1,
            "sanitized_title": "the_topographical_and_neuroanatomical_distribution_of_neurofibrillary_tangles_and_neuritic_plaques_in_the_cerebral_cortex_of_patients_with_alzheimers_disease"
        }
    ],
    "cost": 0.01524275,
    "model_str": "gpt-5-mini"
}</code></pre>
        </div>
        <div class="section">
            <h2>Paper</h2>
            <div class="paper-content"><p>Understanding the Pathophysiology of Alzheimer's Disease and Mild Cognitive Impairment: A Mini Review on fMRI and ERP Studies
Hindawi Publishing CorporationCopyright Hindawi Publishing Corporation</p>
<p>Takao Yamasaki yamasa@neurophy.med.kyushu-u.ac.jp 
Department of Clinical Neurophysiology
Graduate School of Medical Sciences
Neurological Institute
Kyushu University
3-1-1 Maidashi, Higashi-ku812-8582FukuokaJapan</p>
<p>Department of Neurology
Minkodo Minohara Hospital
Sasaguri-machi, Kasuya-gun3553, 811-2402Kanaide, FukuokaJapan</p>
<p>Hiroyuki Muranaka 
Department of Radiology
Hiroshima City General Rehabilitation Center
1-39-1 Tomo-minami, Asaminami-ku731-3168HiroshimaJapan</p>
<p>Yumiko Kaseda 
Department of Neurology
Hiroshima City General Rehabilitation Center
1-39-1 Tomo-minami, Asaminami-ku731-3168HiroshimaJapan</p>
<p>Yasuyo Mimori 
Department of Physical Therapy
Faculty of Health Sciences
Hiroshima International University
555-36, 739-2695Gakuenndai, KuroseHigashihiroshima, HiroshimaJapan</p>
<p>Shozo Tobimatsu 
Department of Clinical Neurophysiology
Graduate School of Medical Sciences
Neurological Institute
Kyushu University
3-1-1 Maidashi, Higashi-ku812-8582FukuokaJapan</p>
<p>Understanding the Pathophysiology of Alzheimer's Disease and Mild Cognitive Impairment: A Mini Review on fMRI and ERP Studies</p>
<p>Neurology Research International
Hindawi Publishing Corporation201210.1155/2012/719056Received 15 March 2011; Revised 11 May 2011; Accepted 15 May 2011Review Article Correspondence should be addressed to Takao Yamasaki, Academic Editor: Antonio Cerasa
The prevalence of Alzheimer's disease (AD) is predicted to increase rapidly in the coming decade, highlighting the importance of early detection and intervention in patients with AD and mild cognitive impairment (MCI). Recently, remarkable advances have been made in the application of neuroimaging techniques in investigations of AD and MCI. Among the various neuroimaging techniques, functional magnetic resonance imaging (fMRI) has many potential advantages, noninvasively detecting alterations in brain function that may be present very early in the course of AD and MCI. In this paper, we first review task-related and resting-state fMRI studies on AD and MCI. We then present our recent fMRI studies with additional event-related potential (ERP) experiments during a motion perception task in MCI. Our results indicate that fMRI, especially when combined with ERP recording, can be useful for detecting spatiotemporal functional changes in AD and MCI patients.</p>
<p>Introduction</p>
<p>Dementia is one of the most serious conditions associated with longevity, and represents a pressing public health problem. Alzheimer's disease (AD) is the most common form of dementia, affecting millions of people around the world. AD is a progressive neurodegenerative disorder, resulting in a gradual, irreversible loss of memory and cognitive function [1]. Recently recognized as the prodromal stage of AD, mild cognitive impairment (MCI) represents a transitional period between normal aging and AD [2,3]. MCI pathology can reveal the early stages of AD, including neuritic plaques, neurofibrillary tangles, and loss of basal forebrain cholinergic neurons [4]. As a subtype of MCI, amnestic MCI constitutes a syndrome presenting with cognitive decline that is more pronounced than expected for the individual's age and educational level, but does not fulfill the criteria for AD. Patients with amnestic MCI have a high risk of AD progression, with a 10-15% yearly transition rate [5]. In addition, large numbers of novel compounds, which have the potential to modify the course of AD and slow its progression, are currently under development. However, there is currently no cure for the disease. For this reason, there is an urgent need for biomarkers to detect MCI.</p>
<p>In the past two decades, several functional imaging techniques have been used to investigate changes in brain 2 Neurology Research International function in patients with AD and MCI. Functional magnetic resonance imaging (fMRI), positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are effective methods. Among these techniques, fMRI has a number of potential advantages for examining patients with AD and MCI, since it is noninvasive, does not require the injection of contrast agent, and has much higher spatial resolution than PET or SPECT. Furthermore, fMRI can be conducted many times over the course of a longitudinal study, and thus lends itself as an appropriate measure in clinical drug trials. Therefore, fMRI is likely to be particularly useful for detecting alterations in brain function that may be present very early in the course of AD and MCI. The measurement of event-related potentials (ERPs) represents a useful objective tool, and has been employed extensively in studying the physiology and pathophysiology of human brain function [6]. ERPs are characterized by extremely high temporal resolution, and can allow noninvasive assessment of synaptic dysfunction in the human brain [7]. Thus, the use of fMRI and ERPs together can provide a powerful tool for examining functional brain abnormalities in AD and MCI.</p>
<p>In this article, we first review previous fMRI studies on AD and MCI. We then present the findings of our recent fMRI studies with additional ERP recording experiments during a motion perception task in MCI patients.</p>
<p>fMRI Findings in AD and MCI</p>
<p>fMRI has been used to investigate abnormalities in patterns of regional brain activation during a variety of cognitive tasks in patients with AD and MCI. In particular, difficulty in the formation and retention of new episodic memories is typically the earliest and most salient clinical symptom of AD [8][9][10]. Even in the early stages of the disease, many patients with AD also exhibit visuospatial deficits [11][12][13]. A large number of fMRI studies have examined memory and visual tasks relative to other types of cognitive task. Furthermore, the recently developed method of measuring resting-state (rs-)fMRI has been used to examine resting brain function in AD and MCI patients [14][15][16]. Below we review studies using task-related (i.e., during memory and visual tasks) fMRI, as well as rs-fMRI studies in patients with AD and MCI.</p>
<p>Memory Networks.</p>
<p>The term "memory" represents a simplified summarization of a wide-ranging set of different associated functions, including short-term, long-term, procedural, declarative, semantic, and episodic memory. Memory can be subdivided into functions related either to the encoding or retrieval of information. The term "declarative memory" refers to the aspect of human memory involved in the storage of facts and experiences, which can be explicitly discussed or declared by the individual. Declarative memory is subdivided into semantic memory (noncontext specific fact, word and object memory) and episodic memory (memory of events, including time, place, and associated emotions). In patients with AD, episodic memory is among the earliest affected functions [8][9][10]. AD typically results in a deficit in the establishment of new episodic memories whereas events dating from more remote periods in the past are better preserved. In the later stages of AD, most other memory domains are also affected. As such, memory impairment is also a fundamental criterion of the diagnosis of AD [17].</p>
<p>The functional neuroanatomy of memory is currently widely believed that many memory functions are tightly linked to distributed regions in the brain. In particular, a neural system in the medial temporal lobe (MTL), including the hippocampal region, and the adjacent perirhinal, entorhinal and parahippocampal cortices, is thought to be involved in encoding and retrieving episodic memory [18][19][20]. In addition, the prefrontal cortical regions, temporoparietal junction, posterior cingulate cortex, and the cerebellum have been identified as contributing to episodic memory [20,21]. In general, brain regions in the left hemisphere (particularly the hippocampus) appear to be more involved in encoding while the right hemisphere (particularly the prefrontal cortex) appears to be more engaged in the retrieval of episodic memory [22]. A specific set of regions, termed the "default mode network" (DMN) has been recently proposed to play a key role in memory, on the basis of rs-fMRI findings [23,24]. The DMN includes the posterior cingulate, extending into the precuneus, lateral parietal, and medial prefrontal regions. This network has been shown to be more metabolically active at rest, decreasing its activity during challenging cognitive tasks. Interestingly, recent fMRI studies have suggested that the DMN needs to be disengaged or "deactivated" during successful memory formation [25,26].</p>
<p>In patients with AD, a number of fMRI studies have reported decreased activation in the MTL region compared with older healthy subjects during episodic encoding tasks [27][28][29] (for a review, see Sperling and colleagues [8][9][10]30]). A recent quantitative meta-analysis [31] demonstrated decreased activation of memory encodingrelated regions (hippocampal formation, ventrolateral prefrontal cortex, precuneus, cingulate gyrus, and lingual gyrus) in AD patients. Other fMRI studies have also suggested that the DMN exhibits markedly abnormal responses during memory tasks in AD patients [32,33]. Interestingly, the regions demonstrating aberrant DMN activity overlap anatomically with regions showing a high amyloid burden in early AD [34].</p>
<p>Regarding MCI patients, fMRI results have been markedly variable, ranging from findings of hyperactivation [27,35] to hypoactivation [36,37] of the MTL region. This variability in the results of previous studies is thought to be closely related to two factors; first, differences in subjects' ability to perform the fMRI task, and second, differences in the severity of the cognitive impairment along a continuum between normal aging and dementia [30]. MTL hyperactivation may be a compensatory response to maintain memory performance in the setting of early AD pathology [30]. As in AD, there is evidence that areas of the DMN are significantly affected in subjects with MCI relative to controls [32,38]. A more recent study using a facename memory task reported that a quantitative goodness-offit index of DMN connectivity was able to distinguish MCI patients who converted to AD from those who remained stable over a 2-to 3-year follow-up period [39].</p>
<p>Visuospatial Perception.</p>
<p>Besides impairment of episodic memory, higher visual dysfunction is one of the cognitive hallmarks of AD [40]. Various visual functions, including the perception of objects, faces, words, and visuospatial stimuli are impaired in AD. However, deficits of visuospatial perception (i.e., the perception of space and motion) are the most prominent. Such deficits play a critical role in the navigational impairment found in AD and MCI [41][42][43].</p>
<p>Visual information is processed via parallel channels, namely, the parvocellular (P) and magnocellular (M) pathways [44] (for review, see Tobimatsu and Celesia [6]). Both systems begin in the retina and project to the primary visual cortex (V1) via the lateral geniculate nucleus. From V1, the P-pathway projects to the ventral stream, which includes V4 and the inferior temporal cortex. This system is responsible for processing form and color [6,44]. Conversely, after V1, the M-pathway projects to the dorsal stream, which includes V3a, V5/MT+ (V5/MT and MST), V6, and the posterior parietal lobule. This system plays an important role in detecting space and motion information [6,44]. Recently, one study reported that the dorsal stream is divided into two functional streams: the dorsodorsal (d-d) and ventrodorsal (v-d) streams [45]. The former consists of V6 and the superior parietal lobule (SPL) whereas the latter is formed by V5/MT and the inferior parietal lobule (IPL). Another series of studies demonstrated that macaque V6 is connected with visual areas including V1-3, V3a, V5/MT+, SPL, and IPL [46,47]. A schematic diagram of the parallel visual pathways is shown in Figure 1. The distribution of neurofibrillary tangles and amyloid deposits in the visual system in typical AD has been described. Neurofibrillary tangles have been found in the visual association areas while amyloid plaques were reported to be uniformly distributed across the primary and association visual areas [4,[48][49][50][51]. In areas along the dorsal pathway, there is a significant loss of long corticocortical projections from early visual areas to V5 [52]. Thus, it is likely that the dorsal visual pathway is more susceptible to putative AD-related neuropathological changes than in the ventral pathway.</p>
<p>Based on the findings mentioned above, several fMRI studies have been conducted to elucidate the neural basis of visuospatial impairment in AD patients [53][54][55]. Information regarding motion perception is independently described in the next section (Section 2.3). Thulborn et al. [53] demonstrated a reduction in right parietal activation while perceiving a visual saccade task. Similarly, Prvulovic et al. [54] reported reduced activation in the SPL, and compensatory recruitment of occipitotemporal cortex (ventral pathway) during the angle discrimination task. Bokde et al. [55] investigated the function of the parallel visual pathways in healthy controls and AD patients, finding that the control group exhibited selective activation of the ventral and dorsal pathways during face-and location-matching tasks. However, no such selective activation was observed in the AD group. Instead, the AD group recruited additional activation in the parietal and frontal lobes during the location-matching task. In contrast, there was no significant difference in activation between the two groups during the face-matching task. These fMRI results thus support the notion that the dorsal visual pathway is more susceptible to putative AD-related neuropathological changes than in the ventral pathway.</p>
<p>In a study of MCI patients, Bokde et al. [57] measured activation changes in the parallel visual pathways using face matching and location-matching tasks. The healthy control group but not the MCI group exhibited selective activation of the ventral and dorsal pathways during the face-and location-matching tasks. During the face-matching task, there was no significant difference in activation between the two groups. However, both visual pathways were activated in the MCI group, possibly reflecting a compensatory mechanism, and increased activation was observed in the left frontal lobe during the location-matching task. Vannini et al. [58] investigated visuospatial processing in progressive and stable MCI patients during an angle discrimination task with varying task demands. Compared with stable MCI patients and controls, progressive MCI patients exhibited a stronger relationship between task demand and brain activity in the left SPL. The authors concluded that increased parietal activation in progressive MCI patients could reflect a reduction in neuronal efficacy in the dorsal pathway due to accumulating AD pathology.</p>
<p>Motion Perception.</p>
<p>To our knowledge, there have been two fMRI studies investigating motion perception in AD (but not MCI) patients [59,60]. Thiyagesh et al. [59] used depth and motion stimuli, reporting that an AD group exhibited hypoactivation in V5, SPL, parietooccipital cortex, and the premotor cortices, as well as greater compensatory activation in IPL. Thiyagesh et al. [60] also examined the treatment effects of acetylcholinesterase inhibitors in AD patients, recording fMRI while subjects performed motion perception tasks. They reported increased activation in the left precuneus, left cuneus, left supramarginal gyrus, right parieto-temporal cortex and right IPL after treatment. Furthermore, increased activation in the left precuneus was found to correlate significantly with improved functioning in terms of activities of daily living. These findings suggest that fMRI scanning during motion perception tasks could be useful for monitoring the efficacy of disease modifying therapies. However, further fMRI studies are necessary to elucidate the neural basis of impaired motion perception in patients with AD and MCI. Motion information is mainly processed by the dorsal stream including V3a, V5/MT+ (V5/MT and MST), V6, and the posterior parietal lobule [6,[44][45][46][47]61]. In particular, the lateral motion area V5/MT+ (V5/MT and MST) and medial motion area V6 have been recently considered key structures in extrastriate motion processing [61]. Human V5/MT+ is functionally and anatomically located in the depths of the anterior occipital sulcus (the ascending limb of the inferior temporal sulcus) and the anterior portions of either the inferior lateral occipital or the inferior occipital sulcus. V5/MT has a high density of motion-sensitive neurons. V1 neurons have small receptive fields that can detect local motion. The properties of V5/MT neurons include larger receptive fields than V1, center-surround interactions, integration of different directions, and sensitivity to motion coherence. Taken together, these findings suggest that V5/MT integrates local motion signals from V1 into the more global representations of motion needed as a basis for perceptual performance. Projections from V5/MT into the neighboring MST area and into the parietal lobe appear to provide a good neural substrate for the use of visual motion in the control of eye movements and other actions (for review, see Tobimatsu and Celesia [6]; Yamasaki et al. [56]).</p>
<p>Recent findings have led to V6 being considered an additional medial motion area [61], located in the parietooccipital sulcus of macaques and humans. In macaques, V6 abuts the end (the representation of the far periphery) of V3 and V3a. It has a clear retinotopic organization, representing the contralateral hemifield. Most of its cells are visually responsive, and approximately 75% are direction sensitive. Similar to V5/MT+ cells, the receptive field of cells in V6 is much larger than that of cells in V1. Adjacent area V6a, which occupies the dorsal/anterior portion of the sulcus, has no obvious retinotopic organization and only around 60% of the neurons are visually responsive. Visual neurons are again predominantly motion sensitive. These findings suggest that macaque V6 and V6a play a pivotal role in providing visual motion information to the motor system. Similarly, human V6 is confined to the dorsal portion of the parieto-occipital sulcus, occupying the fundus and posterior bank of the sulcus. This area contains a complete representation of the contralateral hemifield, with the lower field located medially and more anterior to V3/V3a, extending dorsally to the upper field. As in primates, human V6 responds to coherent more than incoherent motion (for review, see Fattori et al. [46]).</p>
<p>Many types of motion stimuli have been applied to examine motion processing in healthy humans and several neurological disorders. In particular, coherent motion stimuli using random dots have been widely used in psychophysical, electrophysiological, and neuroimaging studies to investigate global motion processing [62][63][64]. There are several types of global motion, including radial optic flow (OF) and horizontal motion (HO; Figure 2). Radial OF, the visual motion perceived during observer self-movement, is particularly important for daily life because it provides cues about the direction and three-dimensional structure of the visual environment [65,66] (for review, see Tobimatsu and Celesia [6]; Yamasaki et al. [56]). In primates, MST and posterior parietal neurons have been found to selectively respond to OF [67,68] while V5/MT neurons do not appear to exhibit such specific selectivity [69]. Several neuropsychological studies have reported that patients with AD exhibited impaired radial OF perception, associated with visuospatial disorientation, but preserved HO perception [70,71]. Some patients with MCI have also been found to exhibit selective impairments in OF perception [43]. These findings suggest differential processing of OF and HO. fMRI studies with healthy subjects have demonstrated that several areas within the dorsal streams are activated by OF [64,[72][73][74]. However, it remains unknown how OF and HO are differentially processed within Neurology Research International 5 the two distinct dorsal streams (the v-d and d-d streams) in healthy subjects as well as in patients with cognitive decline.</p>
<p>Brain Connectivity in the Resting State.</p>
<p>As mentioned above, a number of fMRI studies have revealed that patterns of activation or deactivation during task performance are altered in AD and MCI patients. However, these task-based imaging paradigms require the active participation of subjects, which may be difficult for some AD and MCI patients, depending on the task demands involved. This problem can be resolved by the development of rs-fMRI, a technique that has attracted substantial research attention. rs-fMRI signals are thought to reflect spontaneous neuronal activity and/or the endogenous/background neurophysiological processes of the brain in the resting state [75][76][77]. Because no stimulation or task-related responses are required, this method has practical advantages for clinical applications and can be used easily even for patients with severe dementia [14]. Various methods exist for analyzing rs-fMRI data: seed region of interest (ROI) based on functional connectivity analysis, independent components analysis, clustering, pattern classification, graph theoretical analysis, and "local" methods, including the measurement of regional homogeneity. The characteristics of each of these methods have been described in detail elsewhere (for a review, see Margulies et al. [78]). Spontaneous brain activity is thought to be organized by synchronized oscillations at different temporal and spatial scales [79]. Temporal correlations between low-frequency oscillations of fMRI signals derived from distinct brain areas at rest reflect the spatial aspects of this organization. Biswal et al. [75] reported the first such findings of atrest functional connectivity in the somatomotor system in healthy subjects. Since then, rs-networks have been reported for many functional systems, including the motor, primary sensory, language, attention, and DMN systems [80][81][82][83][84]. In the past several years, many researchers have begun to study the pathophysiology of AD and MCI by investigating changes in rs-fMRI signals (for a review see Liu et al. [14], Sorg et al. [15], and Filippi and Agosta [16]). An rs-fMRI study using seed ROI analysis demonstrated disrupted left-right hippocampal connectivity in AD patients [85]. Other seed-ROI rs-fMRI studies of AD patients reported altered connectivity between the hippocampus and several neocortical regions including the posterior cingulate cortex (PCC), lateral temporal cortex, medial, and lateral prefrontal cortices, and inferior parietal cortex [86][87][88]. A study of MCI patients revealed decreased functional connectivity between the PCC and temporal cortex compared to controls [89]. Whole-brain analyses of MCI patients have also reported diffuse alterations of connectivity in the DMN compared with healthy elderly controls [90,91]. For example, Sorg et al. [90] revealed decreased DMN connectivity not only in the PCC and the bilateral parietal cortex, but also in the right medial prefrontal cortex. Qi et al. [91] reported decreased functional activity in regions associated with the DMN, including the bilateral precuneus/PCC, right IPL and left fusiform gyrus, and a trend towards decreased right medial temporal lobe activity. In contrast, enhanced rsfunctional connectivity in frontal regions has been reported in AD patients [92][93][94]. Increased functional connectivity between regions of the DMN and frontal areas has also been reported in AD [93] and MCI patients [89,91]. These findings suggest that patients with AD may rely on increased prefrontal connectivity to compensate for reduced temporal lobe function.</p>
<p>Disruption of global functional organization has also been reported in AD [92,94]. Wang et al. [94] found that AD patients exhibited decreased positive correlations of activity between the prefrontal and parietal lobes, but increased positive correlations within the prefrontal, parietal, and occipital lobes. These findings provide further evidence for the notion that anterior-posterior disconnection and increased within-lobe functional connectivity occur in AD. Supekar et al. [92] investigated small-world properties in the brain, namely, the clustering coefficients and characteristic path lengths of 90 brain nodes in AD patients, as indices of global functional organization. Clustering coefficients are considered a measure of local network connectivity, and networks with high average clustering coefficients are characterized by densely connected local clusters. The characteristic path length is a measure of how well connected a network is. A network with a low characteristic path length exhibits short distances between any two nodes. Small-world networks are characterized by a high clustering coefficient and a low characteristic path length. Based on graph theoretical analysis, AD patients were found to exhibit a loss of small-world properties in the brain, with a significant reduction in the clustering coefficient. This finding suggests the involvement of disrupted local connectivity in the disease [92]. In addition, a trend towards randomness in brain networks in AD was recently reported by Sanz-Arigita et al. [95] using graph analysis. A post hoc analysis of regional synchronization revealed increased synchronization in AD involving the frontal cortices and occipital regions. This translates into a global reduction of functional long-distance links between frontal and caudal brain regions.</p>
<p>Recently, Chen et al. [96] succeeded in classifying patients as AD, MCI, and cognitively normal subjects using a largescale network analysis. The altered connectivity patterns among the cortical networks were significantly correlated with the results of cognitive tests. Zhang et al. [97] investigated alterations in PCC functional connectivity by comparing a healthy control group with three separate AD groups (mild, moderate, and severe AD) using a method of temporal correlation. They found that modulation of the DMN with abnormal PCC connectivity was able to change along with AD stage progression. Thus, changes in functional connectivity of the resting brain may provide an imaging marker for monitoring AD progression.</p>
<p>fMRI with Additional ERP Recording in Motion Perception</p>
<p>fMRI is characterized by excellent spatial resolution, but low temporal resolution. Thus, it can only discriminate between events that are separated by several seconds. In contrast, the temporal resolution of ERPs is in the order of milliseconds, which is far superior to that of other neuroimaging methods including fMRI. However, ERPs offer poor spatial resolution compared with fMRI. Based on these characteristics, the combined use of fMRI and ERPs is considered to be an extremely useful technique for evaluating the spatiotemporal functional changes in AD and MCI in detail. In the following section, we summarize the findings of our studies using fMRI and separate ERP measurement during the performance of motion perception tasks in healthy controls and MCI patients [56,[98][99][100][101][102].</p>
<p>Two Distinct Motion Pathways.</p>
<p>As stated in Section 2.3, it is currently unclear how coherent OF and HO are differently processed in the v-d and d-d streams in humans. We first examined the neural basis of motion perception in healthy young adults by measuring fMRI and visual ERPs during the perception of coherent OF and HO stimuli [56,[98][99][100][101][102]. In our fMRI experiments, we used a block design rather than an event-related design to detect subtle differences in BOLD signals between the responses to the two types of motion stimuli. To complement temporal information associated with neural activity, high-density 128-channel ERPs were separately recorded. Our visual stimuli consisted of 400 white square dots randomly presented on a black background. The white dots moved at a velocity of 5.0 degrees of visual angle per second. The dots in the HO stimuli moved leftward or rightward while those in the OF stimuli moved radially in an outward pattern ( Figure 2). The coherence level was 90% for both types of stimuli. We used random motion (RM) as a baseline in our analysis to suppress the neural activity of nondirectional neurons. When fMRI was recorded during OF and HO perception, the OF stimulus significantly activated the v-d stream, including the IPL (BA 39/40) in the OF minus RM-baseline and OF minus HO contrasts (Figure 3(a)). There was no significant activation in other motion areas, such as V3a, V5/MT+, V6, and the d-d stream (SPL) in either contrast. On the contrary, the d-d stream, including the SPL (BA 7) was significantly activated during perception of the HO stimulus in the HO minus RM-baseline and the HO minus OF contrasts (Figure 3(b)). However, significant activations of V3a, V5/MT+, and the v-d stream (IPL) were not observed in either contrast. These findings indicate that OF and HO motions are processed differently within the dorsal stream. The d-d stream (SPL) appears to be more closely related to HO motion processing while the v-d stream (IPL) is important for OF motion processing [56,98,102]. In addition, the lack of activation in V3a, V5/MT+ and V6 suggests that these brain regions do not distinguish between RM (or incoherent), coherent OF, and HO motion.</p>
<p>Previous studies have reported that the v-d stream, including the IPL, plays crucial roles in high-level motion perception, space perception, and action organization [45,103,104]. Conversely, the SPL is highly responsive to unidirectional coherent motion stimuli [105]. Therefore, the IPL appears to play an important role in complex OF processing while activity in the SPL is related to the processing of simple unidirectional motion. Using the same motion stimuli, we conducted several experiments using high-density 128-channel ERP recording. The results revealed that perception of these stimuli was associated with two major ERP components (N170, P200; Figure 4). The occipitotemporal N170 had a V5/MT origin, and was evoked by both types of stimuli [56,98]. In contrast, the parietal P200 originated in IPL (BA 40) and was only elicited by OF stimuli [56,98]. These findings indicate that the N170 component is a nonspecific, motion-related component originating from V5/MT, while the P200 is an OF-specific component generated by the IPL [56,98]. Thus, our ERP studies provided further evidence suggesting a close relationship between the v-d stream (IPL) and OF perception. On the basis of these findings, we conclude that different types of spatiotemporal processing are driven by OF and HO motion stimuli within two distinct dorsal streams in healthy young adults.</p>
<p>Effects of Aging and Cognitive Decline on Motion Perception.</p>
<p>Based on our previous fMRI and ERP findings in healthy young adults [56,98], we conducted a preliminary investigation of motion perception in healthy older elderly adults and MCI patients. In fMRI, healthy elderly adults showed similar activation patterns to healthy young adults. That is, OF stimulus perception dominantly activated the vd stream (IPL) while the d-d stream (SPL) was more strongly activated by HO stimuli. Interestingly, in MCI patients, IPL activation in response to OF stimuli was decreased compared to healthy elderly adults. In contrast, there was no apparent difference in SPL activation for HO between healthy old adults and MCI patients. These results imply that the function of the v-d stream (IPL) is selectively impaired in MCI while d-d (SPL) function appears to be preserved. Two major ERP components (N170, P200) were detected during this task in both healthy old adults and MCI patients, as observed in healthy young adults [98]. MCI patients exhibited prolonged OF-specific P200 latencies compared to healthy elderly adults, but no differences were found in N170 latency. This finding suggests that the function of the v-d stream (IPL) related to OF perception is selectively impaired in MCI patients, consistent with fMRI findings. These results are in accord with the functional importance of the IPL in MCI patients [106]. Taken together, our findings provide evidence that fMRI with additional ERP recording can be useful for detecting spatiotemporal functional changes in the brain, including the IPL, in MCI patients.</p>
<p>Conclusion</p>
<p>The most prominent symptoms of MCI and AD are memory loss and visuospatial impairments. The task-related fMRI studies discussed in this review demonstrated specific alterations of several brain functions, such as memory networks and visuospatial perception. Decreased activation in the distributed networks including the MTL and DMN has been observed during the encoding of new memories. Alteration of memory networks can distinguish AD converters of MCI from nonconverters. During visuospatial perception, the activation of the dorsal pathway was reduced in conjunction with compensatory activation in the ventral pathway and frontal regions. Repeated fMRI scanning during a visuospatial task revealed enhanced activation in the dorsal stream after treatment. This activation was correlated with improvements on neuropsychological assessments. Studies utilizing the recent development of rs-fMRI have also demonstrated altered functional connectivity within the hippocampus, DMN, and larger-scale networks. Changes in the functional connectivity of the resting brain have been successfully used in the classification of patients with AD, MCI, and the healthy elderly. Taken together, the studies reviewed above indicate that fMRI is useful as an early diagnostic aid for AD and MCI patients. Furthermore, fMRI is a potentially useful method for monitoring the progression of disease and the efficacy of disease-modifying therapies. Unfortunately, the temporal resolution of fMRI is far inferior to that of ERPs. By recording both fMRI and ERP activity in response to the same motion stimuli, we revealed spatiotemporal functional changes of the IPL in MCI patients during coherent motion perception. Therefore, the use of ERPs appears to provide additional information about spatiotemporal functional changes in MCI.</p>
<p>Figure 1 :
1The parallel visual pathways in humans. Abbreviations in this and subsequent figures: d-d pathway, dorsodorsal pathway; vd pathway, ventrodorsal pathway; LGN: lateral geniculate nucleus; V1, 2, 3, 4, and 6, primary, secondary, tertiary, quaternary, and senary visual cortices; V3a, V3 accessory; V5/MT: quinary visual cortex/middle temporal area; MST: medial superior temporal area; IPL, inferior parietal lobule, SPL: superior parietal lobule; IT: inferior temporal cortex.</p>
<p>Figure 2 :
2Visual motion stimuli. Four hundred white square dots (visual angle, 0.2 × 0.2 • ; luminance, 48 cd/m 2 ) were randomly presented on a black background (visual angle, 50 × 48 • ; luminance, 0.1 cd/m 2 ). The contrast level was 99.6%. The white dots moved at a velocity of 5.0 • /s. When the white dots move incoherently, random motion stimulation is created. When the white dots move coherently, OF and HO are perceived. Abbreviations in this and subsequent figures: HO: horizontal motion; OF: optic flow (adapted from Yamasaki et al., in press [56]).</p>
<p>Figure 3 :
3fMRI responses in healthy young adults. (a) Activations of the v-d pathway including the IPL (BA 39/40) are found in the OF minus HO condition. (b) The HO minus OF condition shows the activation of the d-d pathway, including the SPL (BA 7; adapted from Yamasaki et al., in press [56]).</p>
<p>Figure 4 :
4ERP responses in healthy young adults. Two major components (N170, P200) were observed. The N170 was evoked by both HO and OF stimuli while the P200 was only elicited by OF stimuli (adapted fromYamasaki et al., in press [56]).
Acknowledgments
Alzheimer disease: time to improve its diagnosis and treatment. S Salloway, S Correia, Cleveland Clinic Journal of Medicine. 761S. Salloway and S. Correia, "Alzheimer disease: time to improve its diagnosis and treatment," Cleveland Clinic Jour- nal of Medicine, vol. 76, no. 1, pp. 49-58, 2009.</p>
<p>Mild cognitive impairment: clinical characterization and outcome. R C Petersen, G E Smith, S C Waring, R J Ivnik, E G Tangalos, E Kokmen, Archives of Neurology. 563R. C. Petersen, G. E. Smith, S. C. Waring, R. J. Ivnik, E. G. Tangalos, and E. Kokmen, "Mild cognitive impairment: clinical characterization and outcome," Archives of Neurology, vol. 56, no. 3, pp. 303-308, 1999.</p>
<p>Mild cognitive impairment: conceptual basis and current nosological status. K Ritchie, J Touchon, The Lancet. 3559199K. Ritchie and J. Touchon, "Mild cognitive impairment: conceptual basis and current nosological status," The Lancet, vol. 355, no. 9199, pp. 225-228, 2000.</p>
<p>Neuropathological stageing of Alzheimer-related changes. H Braak, E Braak, Acta Neuropathologica. 824H. Braak and E. Braak, "Neuropathological stageing of Alzheimer-related changes," Acta Neuropathologica, vol. 82, no. 4, pp. 239-259, 1991.</p>
<p>Current concepts in mild cognitive impairment. R C Petersen, R Doody, A Kurz, Archives of Neurology. 5812R. C. Petersen, R. Doody, A. Kurz et al., "Current concepts in mild cognitive impairment," Archives of Neurology, vol. 58, no. 12, pp. 1985-1992, 2001.</p>
<p>Studies of human visual pathophysiology with visual evoked potentials. S Tobimatsu, G G Celesia, Clinical Neurophysiology. 1177S. Tobimatsu and G. G. Celesia, "Studies of human visual pathophysiology with visual evoked potentials," Clinical Neurophysiology, vol. 117, no. 7, pp. 1414-1433, 2006.</p>
<p>Synaptic dysfunction in Alzheimer's disease: clinical assessment using quantitative EEG. I A Cook, A F Leuchter, Behavioural Brain Research. 781I. A. Cook and A. F. Leuchter, "Synaptic dysfunction in Alzheimer's disease: clinical assessment using quantitative EEG," Behavioural Brain Research, vol. 78, no. 1, pp. 15-23, 1996.</p>
<p>Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies. B C Dickerson, R A Sperling, Neuropsychologia. 466B. C. Dickerson and R. A. Sperling, "Functional abnormal- ities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies," Neuropsychologia, vol. 46, no. 6, pp. 1624-1635, 2008.</p>
<p>. Neurology Research International. Neurology Research International</p>
<p>Large-scale functional brain network abnormalities in Alzheimer's disease: insights from functional neuroimaging. B C Dickerson, R A Sperling, Behavioural Neurology. 211-2B. C. Dickerson and R. A. Sperling, "Large-scale functional brain network abnormalities in Alzheimer's disease: insights from functional neuroimaging," Behavioural Neurology, vol. 21, no. 1-2, pp. 63-75, 2009.</p>
<p>Functional alterations in memory networks in early Alzheimer's disease. R A Sperling, B C Dickerson, M Pihlajamaki, NeuroMolecular Medicine. 121R. A. Sperling, B. C. Dickerson, M. Pihlajamaki et al., "Func- tional alterations in memory networks in early Alzheimer's disease," NeuroMolecular Medicine, vol. 12, no. 1, pp. 27-43, 2010.</p>
<p>Perception of movement and shape in Alzheimer's disease. M Rizzo, M Nawrot, Brain. 12112M. Rizzo and M. Nawrot, "Perception of movement and shape in Alzheimer's disease," Brain, vol. 121, no. 12, pp. 2259-2270, 1998.</p>
<p>Visual loss and getting lost in Alzheimer's disease. S J Tetewsky, C J Duffy, Neurology. 525S. J. Tetewsky and C. J. Duffy, "Visual loss and getting lost in Alzheimer's disease," Neurology, vol. 52, no. 5, pp. 958-965, 1999.</p>
<p>Depth perception in Alzheimer's disease. M F Mendez, M M Cherrier, R S Meadows, Perceptual and Motor Skills. 853M. F. Mendez, M. M. Cherrier, and R. S. Meadows, "Depth perception in Alzheimer's disease," Perceptual and Motor Skills, vol. 85, no. 3, pp. 987-995, 1996.</p>
<p>Regional homogeneity, functional connectivity and imaging markers of Alzheimer's disease: a review of resting-state fMRI studies. Y Liu, K Wang, C Yu, Neuropsychologia. 466Y. Liu, K. Wang, C. YU et al., "Regional homogeneity, functional connectivity and imaging markers of Alzheimer's disease: a review of resting-state fMRI studies," Neuropsy- chologia, vol. 46, no. 6, pp. 1648-1656, 2008.</p>
<p>Impact of Alzheimer's disease on the functional connectivity of spontaneous brain activity. C Sorg, V Riedl, R Perneczky, A Kurz, A M Wohlschläger, Current Alzheimer Research. 66C. Sorg, V. Riedl, R. Perneczky, A. Kurz, and A. M. Wohlschläger, "Impact of Alzheimer's disease on the func- tional connectivity of spontaneous brain activity," Current Alzheimer Research, vol. 6, no. 6, pp. 541-553, 2009.</p>
<p>Structural and functional network connectivity breakdown in Alzheimer's disease studied with magnetic resonance imaging techniques. M Filippi, F Agosta, Journal of Alzheimer's Disease. 243M. Filippi and F. Agosta, "Structural and functional net- work connectivity breakdown in Alzheimer's disease studied with magnetic resonance imaging techniques," Journal of Alzheimer's Disease, vol. 24, no. 3, pp. 455-474, 2011.</p>
<p>Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. G Mckhann, D Drachman, M Folstein, R Katzman, D Price, E M Stadlan, Neurology. 347G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E. M. Stadlan, "Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease," Neurology, vol. 34, no. 7, pp. 939-944, 1984.</p>
<p>Memory systems of the brain: a brief history and current perspective. L R Squire, Neurobiology of Learning and Memory. 823L. R. Squire, "Memory systems of the brain: a brief history and current perspective," Neurobiology of Learning and Memory, vol. 82, no. 3, pp. 171-177, 2004.</p>
<p>The medial temporal lobe. L R Squire, C E Stark, R E Clark, Annual Review of Neuroscience. 27L. R. Squire, C. E. Stark, and R. E. Clark, "The medial temporal lobe," Annual Review of Neuroscience, vol. 27, pp. 279-306, 2004.</p>
<p>The functional neuroanatomy of episodic memory: the role of the frontal lobes, the hippocampal formation, and other areas. B Desgranges, J C Baron, F Eustache, Neuroimage. 82B. Desgranges, J. C. Baron, and F. Eustache, "The functional neuroanatomy of episodic memory: the role of the frontal lobes, the hippocampal formation, and other areas," Neu- roimage, vol. 8, no. 2, pp. 198-213, 1998.</p>
<p>The functional neuroanatomy of autobiographical memory: a metaanalysis. E Svoboda, M C Mckinnon, B Levine, Neuropsychologia. 4412E. Svoboda, M. C. McKinnon, and B. Levine, "The func- tional neuroanatomy of autobiographical memory: a meta- analysis," Neuropsychologia, vol. 44, no. 12, pp. 2189-2208, 2006.</p>
<p>Hemispheric encoding/retrieval asymmetry in episodic memory: positron emission tomography findings. E Tulving, S Kapur, F I Craik, M Moscovitch, S Houle, Proceedings of the National Academy of Sciences of the United States of America. the National Academy of Sciences of the United States of America91E. Tulving, S. Kapur, F. I. Craik, M. Moscovitch, and S. Houle, "Hemispheric encoding/retrieval asymmetry in episodic memory: positron emission tomography findings," Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 6, pp. 2016-2020, 1994.</p>
<p>A default mode of brain function. M E Raichle, A M Macleod, A Z Snyder, W J Powers, D A Gusnard, G L Shulman, Proceedings of the National Academy of Sciences of the United States of America. 982M. E. Raichle, A. M. MacLeod, A. Z. Snyder, W. J. Powers, D. A. Gusnard, and G. L. Shulman, "A default mode of brain function," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 2, pp. 676-682, 2001.</p>
<p>The brain's default network: anatomy, function, and relevance to disease. R L Buckner, J R Andrews-Hanna, D L Schacter, Annals of the New York Academy of Sciences. 1124R. L. Buckner, J. R. Andrews-Hanna, and D. L. Schacter, "The brain's default network: anatomy, function, and relevance to disease," Annals of the New York Academy of Sciences, vol. 1124, pp. 1-38, 2008.</p>
<p>When less means more: deactivations during encoding that predict subsequent memory. S M Daselaar, S E Prince, R Cabeza, Neuroimage. 233S. M. Daselaar, S. E. Prince, and R. Cabeza, "When less means more: deactivations during encoding that predict subsequent memory," Neuroimage, vol. 23, no. 3, pp. 921-927, 2004.</p>
<p>Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline. S L Miller, E Fenstermacher, J Bates, D Blacker, R A Sperling, B C Dickerson, Neurosurgery and Psychiatry. 796Journal of NeurologyS. L. Miller, E. Fenstermacher, J. Bates, D. Blacker, R. A. Sperling, and B. C. Dickerson, "Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline," Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 6, pp. 630-635, 2008.</p>
<p>Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. S A Small, G M Perera, R Delapaz, R Mayeux, Y Stern, Annals of Neurology. 454S. A. Small, G. M. Perera, R. DeLaPaz, R. Mayeux, and Y. Stern, "Differential regional dysfunction of the hippocam- pal formation among elderly with memory decline and Alzheimer's disease," Annals of Neurology, vol. 45, no. 4, pp. 466-472, 1999.</p>
<p>Memory encoding in Alzheimer's disease: an fMRI study of explicit and implicit memory. A Golby, G Silverberg, E Race, Brain. 1284A. Golby, G. Silverberg, E. Race et al., "Memory encoding in Alzheimer's disease: an fMRI study of explicit and implicit memory," Brain, vol. 128, no. 4, pp. 773-787, 2005.</p>
<p>Verbal episodic memory impairment in Alzheimer's disease: a combined structural and functional MRI study. F Rémy, F Mirrashed, B Campbell, W Richter, Neuroimage. 251F. Rémy, F. Mirrashed, B. Campbell, and W. Richter, "Verbal episodic memory impairment in Alzheimer's disease: a combined structural and functional MRI study," Neuroimage, vol. 25, no. 1, pp. 253-266, 2005.</p>
<p>Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease. R Sperling, Annals of the New York Academy of Sciences. 1097R. Sperling, "Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease," Annals of the New York Academy of Sciences, vol. 1097, pp. 146-155, 2007.</p>
<p>Functional imaging studies of episodic memory in Alzheimer's disease: a quantitative meta-analysis. G C Schwindt, S E Black, Neuroimage. 451G. C. Schwindt and S. E. Black, "Functional imaging studies of episodic memory in Alzheimer's disease: a quantitative meta-analysis," Neuroimage, vol. 45, no. 1, pp. 181-190, 2009.</p>
<p>Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. K A Celone, V D Calhoun, B C Dickerson, The Journal of Neuroscience. 2640K. A. Celone, V. D. Calhoun, B. C. Dickerson et al., "Alterations in memory networks in mild cognitive impair- ment and Alzheimer's disease: an independent component analysis," The Journal of Neuroscience, vol. 26, no. 40, pp. 10222-10231, 2006.</p>
<p>Impaired medial temporal repetition suppression is related to failure of parietal deactivation in Alzheimer disease. M Pihlajamäsignki, K M Depeau, D Blacker, R A Sperling, The American Journal of Geriatric Psychiatry. 164M. Pihlajamäsignki, K. M. DePeau, D. Blacker, and R. A. Sperling, "Impaired medial temporal repetition suppression is related to failure of parietal deactivation in Alzheimer disease," The American Journal of Geriatric Psychiatry, vol. 16, no. 4, pp. 283-292, 2008.</p>
<p>Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. W E Klunk, H Engler, A Nordberg, Annals of Neurology. 553W. E. Klunk, H. Engler, A. Nordberg et al., "Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound- B," Annals of Neurology, vol. 55, no. 3, pp. 306-319, 2004.</p>
<p>Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. M M Machulda, H A Ward, B Borowski, Neurology. 614M. M. Machulda, H. A. Ward, B. Borowski et al., "Compar- ison of memory fMRI response among normal, MCI, and Alzheimer's patients," Neurology, vol. 61, no. 4, pp. 500-506, 2003.</p>
<p>Increased fMRI responses during encoding in mild cognitive impairment. A Hämäläinen, M Pihlajamäki, H Tanila, Neurobiology of Aging. 2812A. Hämäläinen, M. Pihlajamäki, H. Tanila et al., "Increased fMRI responses during encoding in mild cognitive impair- ment," Neurobiology of Aging, vol. 28, no. 12, pp. 1889-1903, 2007.</p>
<p>Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. B C Dickerson, D H Salat, D N Greve, Neurology. 653B. C. Dickerson, D. H. Salat, D. N. Greve et al., "Increased hippocampal activation in mild cognitive impairment com- pared to normal aging and AD," Neurology, vol. 65, no. 3, pp. 404-411, 2005.</p>
<p>Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. C Sorg, V Riedl, M Mühlau, Proceedings of the National Academy of Sciences of the United States of America. the National Academy of Sciences of the United States of America104C. Sorg, V. Riedl, M. Mühlau et al., "Selective changes of resting-state networks in individuals at risk for Alzheimer's disease," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 47, pp. 18760-18765, 2007.</p>
<p>Default mode network connectivity in stable vs progressive mild cognitive impairment. J R Petrella, F C Sheldon, S E Prince, V D Calhoun, P M Doraiswamy, Neurology. 766J. R. Petrella, F. C. Sheldon, S. E. Prince, V. D. Calhoun, and P. M. Doraiswamy, "Default mode network connectivity in stable vs progressive mild cognitive impairment," Neurology, vol. 76, no. 6, pp. 511-517, 2011.</p>
<p>Complex visual disturbances in Alzheimer's disease. M F Mendez, M A Mendez, R Martin, K A Smyth, P J Whitehouse, Neurology. 403M. F. Mendez, M. A. Mendez, R. Martin, K. A. Smyth, and P. J. Whitehouse, "Complex visual disturbances in Alzheimer's disease," Neurology, vol. 40, no. 3, pp. 439-443, 1990.</p>
<p>Visual dysfunction in Alzheimer's disease: relation to normal aging. A Cronin-Golomb, S Corkin, J F Rizzo, J Cohen, J H Growdon, K S Banks, Annals of Neurology. 291A. Cronin-Golomb, S. Corkin, J. F. Rizzo, J. Cohen, J. H. Growdon, and K. S. Banks, "Visual dysfunction in Alzheimer's disease: relation to normal aging," Annals of Neurology, vol. 29, no. 1, pp. 41-52, 1991.</p>
<p>. Neurology Research International. 9Neurology Research International 9</p>
<p>Visualspatial deficits explain visual symptoms in Alzheimer's disease. C M Butter, J D Trobe, N L Foster, S Berent, American Journal of Ophthalmology. 1221C. M. Butter, J. D. Trobe, N. L. Foster, and S. Berent, "Visual- spatial deficits explain visual symptoms in Alzheimer's disease," American Journal of Ophthalmology, vol. 122, no. 1, pp. 97-105, 1996.</p>
<p>A visuospatial variant of mild cognitive impairment: getting lost between aging and AD. M Mapstone, T M Steffenella, C J Duffy, Neurology. 605M. Mapstone, T. M. Steffenella, and C. J. Duffy, "A visu- ospatial variant of mild cognitive impairment: getting lost between aging and AD," Neurology, vol. 60, no. 5, pp. 802- 808, 2003.</p>
<p>Segregation of form, color, movement, and depth: anatomy, physiology, and perception. M Livingstone, D Hubel, Science. 2404853M. Livingstone and D. Hubel, "Segregation of form, color, movement, and depth: anatomy, physiology, and perception," Science, vol. 240, no. 4853, pp. 740-749, 1988.</p>
<p>Two different streams form the dorsal visual system: anatomy and functions. G Rizzolatti, M Matelli, Experimental Brain Research. 1532G. Rizzolatti and M. Matelli, "Two different streams form the dorsal visual system: anatomy and functions," Experimental Brain Research, vol. 153, no. 2, pp. 146-157, 2003.</p>
<p>The cortical visual area V6 in macaque and human brains. P Fattori, S Pitzalis, C Galletti, Journal of Physiology-Paris. 1031-2P. Fattori, S. Pitzalis, and C. Galletti, "The cortical visual area V6 in macaque and human brains," Journal of Physiology- Paris, vol. 103, no. 1-2, pp. 88-97, 2009.</p>
<p>Cortical connections of the visuomotor parietooccipital area V6Ad of the macaque monkey. M Gamberini, L Passarelli, P Fattori, The Journal of Comparative Neurology. 5136M. Gamberini, L. Passarelli, P. Fattori et al., "Cortical connections of the visuomotor parietooccipital area V6Ad of the macaque monkey," The Journal of Comparative Neurology, vol. 513, no. 6, pp. 622-642, 2009.</p>
<p>Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. R C Pearson, M M Esiri, R W Hiorns, G K Wilcock, T P Powell, Proceedings of the National Academy of Sciences of the United States of America. 8213R. C. Pearson, M. M. Esiri, R. W. Hiorns, G. K. Wilcock, and T. P. Powell, "Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease," Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 13, pp. 4531-4534, 1985.</p>
<p>Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease. J Rogers, J H Morrison, The Journal of Neuroscience. 510J. Rogers and J. H. Morrison, "Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease," The Journal of Neuroscience, vol. 5, no. 10, pp. 2801-2808, 1985.</p>
<p>Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. D A Lewis, M J Campbell, R D Terry, J H Morrison, The Journal of Neuroscience. 76D. A. Lewis, M. J. Campbell, R. D. Terry, and J. H. Morrison, "Laminar and regional distributions of neurofib- rillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices," The Journal of Neuroscience, vol. 7, no. 6, pp. 1799-1808, 1987.</p>
<p>The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. S E Arnold, B T Hyman, J Flory, A R Damasio, G W Van Hoesen, Cerebral Cortex. 11S. E. Arnold, B. T. Hyman, J. Flory, A. R. Damasio, and G. W. Van Hoesen, "The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease," Cerebral Cortex, vol. 1, no. 1, pp. 103-116, 1991.</p>
<p>Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex. P R Hof, J H Morrison, The Journal of Comparative Neurology. 3011P. R. Hof and J. H. Morrison, "Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex," The Journal of Comparative Neurology, vol. 301, no. 1, pp. 55-64, 1990.</p>
<p>Functional MR imaging using a visually guided saccade paradigm for comparing activation patterns in patients with probable Alzheimer's disease and in cognitively able elderly volunteers. K R Thulborn, C Martin, J T Voyvodic, American Journal of Neuroradiology. 213K. R. Thulborn, C. Martin, and J. T. Voyvodic, "Functional MR imaging using a visually guided saccade paradigm for comparing activation patterns in patients with probable Alzheimer's disease and in cognitively able elderly volun- teers," American Journal of Neuroradiology, vol. 21, no. 3, pp. 524-531, 2000.</p>
<p>Functional imaging of visuospatial processing in Alzheimer's disease. D Prvulovic, D Hubl, A T Sack, Neuroimage. 173D. Prvulovic, D. Hubl, A. T. Sack et al., "Functional imaging of visuospatial processing in Alzheimer's disease," Neuroimage, vol. 17, no. 3, pp. 1403-1414, 2002.</p>
<p>Alzheimer disease: functional abnormalities in the dorsal visual pathway. A L W Bokde, P Lopez-Bayo, C Born, Radiology. 2541A. L. W. Bokde, P. Lopez-Bayo, C. Born et al., "Alzheimer dis- ease: functional abnormalities in the dorsal visual pathway," Radiology, vol. 254, no. 1, pp. 219-226, 2010.</p>
<p>Motion perception in autism spectrum disorder. T Yamasaki, T Fujita, Y Kamio, S Tobimatsu, Advances in Psychology Research, A. M. Columbus. New York, NY, USANova Science Publishers82in pressT. Yamasaki, T. Fujita, Y. Kamio, and S. Tobimatsu, "Motion perception in autism spectrum disorder," in Advances in Psychology Research, A. M. Columbus, Ed., vol. 82, Nova Science Publishers, New York, NY, USA, in press.</p>
<p>Functional abnormalities of the visual processing system in subjects with mild cognitive impairment: an fMRI study. A L W Bokde, P Lopez-Bayo, C Born, Psychiatry Research. 1633A. L. W. Bokde, P. Lopez-Bayo, C. Born et al., "Functional abnormalities of the visual processing system in subjects with mild cognitive impairment: an fMRI study," Psychiatry Research, vol. 163, no. 3, pp. 248-259, 2008.</p>
<p>Reduced neuronal efficacy in progressive mild cognitive impairment: a prospective fMRI study on visuospatial processing. P Vannini, O Almkvist, T Dierks, C Lehmann, L O Wahlund, Psychiatry Research. 1561P. Vannini, O. Almkvist, T. Dierks, C. Lehmann, and L. O. Wahlund, "Reduced neuronal efficacy in progressive mild cognitive impairment: a prospective fMRI study on visuospatial processing," Psychiatry Research, vol. 156, no. 1, pp. 43-57, 2007.</p>
<p>The neural basis of visuospatial perception in Alzheimer's disease and healthy elderly comparison subjects: an fMRI study. S N Thiyagesh, T F D Farrow, R W Parks, Psychiatry Research. 1722S. N. Thiyagesh, T. F. D. Farrow, R. W. Parks et al., "The neural basis of visuospatial perception in Alzheimer's disease and healthy elderly comparison subjects: an fMRI study," Psychiatry Research, vol. 172, no. 2, pp. 109-116, 2009.</p>
<p>Treatment effects of therapeutic cholinesterase inhibitors on visuospatial processing in Alzheimer's disease: a longitudinal functional MRI study. S N Thiyagesh, T F D Farrow, R W Parks, Dementia and Geriatric Cognitive Disorders. 292S. N. Thiyagesh, T. F. D. Farrow, R. W. Parks et al., "Treatment effects of therapeutic cholinesterase inhibitors on visuospatial processing in Alzheimer's disease: a longitudinal functional MRI study," Dementia and Geriatric Cognitive Disorders, vol. 29, no. 2, pp. 176-188, 2010.</p>
<p>Human V6: the medial motion area. S Pitzalis, M I Sereno, G Committeri, Cerebral Cortex. 202S. Pitzalis, M. I. Sereno, G. Committeri et al., "Human V6: the medial motion area," Cerebral Cortex, vol. 20, no. 2, pp. 411-424, 2010.</p>
<p>A selective impairment of motion perception following lesions of the middle temporal visual area (MT). W T Newsome, E B Paré, The Journal of Neuroscience. 86W. T. Newsome and E. B. Paré, "A selective impairment of motion perception following lesions of the middle temporal visual area (MT)," The Journal of Neuroscience, vol. 8, no. 6, pp. 2201-2211, 1988.</p>
<p>Characteristics of visual evoked potentials generated by motion coherence onset. M Niedeggen, E R Wist, Cognitive Brain Research. 82M. Niedeggen and E. R. Wist, "Characteristics of visual evoked potentials generated by motion coherence onset," Cognitive Brain Research, vol. 8, no. 2, pp. 95-105, 1999.</p>
<p>A cortical area that responds specifically to optic flow, revealed by fMRI. M C Morrone, M Tosetti, D Montanaro, A Fiorentini, G Cioni, D C Burr, Nature Neuroscience. 312M. C. Morrone, M. Tosetti, D. Montanaro, A. Fiorentini, G. Cioni, and D. C. Burr, "A cortical area that responds specif- ically to optic flow, revealed by fMRI," Nature Neuroscience, vol. 3, no. 12, pp. 1322-1328, 2000.</p>
<p>The Perception of the Visual World. J J Gibson, Houghton Mifflin; Boston, Mass, USAJ. J. Gibson, The Perception of the Visual World, Houghton Mifflin, Boston, Mass, USA, 1950.</p>
<p>Direction of self-motion is perceived from optical flow. W H Warren, D J Hannon, Nature. 3366195W. H. Warren and D. J. Hannon, "Direction of self-motion is perceived from optical flow," Nature, vol. 336, no. 6195, pp. 162-163, 1988.</p>
<p>Analysis of motion of the visual field by direction, expansion/contraction, and rotation cells clustered in the dorsal part of the medial superior temporal area of the macaque monkey. K Tanaka, H A Saito, Journal of Neurophysiology. 623K. Tanaka and H. A. Saito, "Analysis of motion of the visual field by direction, expansion/contraction, and rotation cells clustered in the dorsal part of the medial superior temporal area of the macaque monkey," Journal of Neurophysiology, vol. 62, no. 3, pp. 626-641, 1989.</p>
<p>Analysis of optic flow in the monkey parietal area 7a. R M Siegel, H L Reid, Cerebral Cortex. 74R. M. Siegel and H. L. Reid, "Analysis of optic flow in the monkey parietal area 7a," Cerebral Cortex, vol. 7, no. 4, pp. 327-346, 1997.</p>
<p>Motion selectivity in macaque visual cortex. I. Mechanisms of direction and speed selectivity in extrastriate area MT. A Mikami, W T Newsome, R H Wurtz, Journal of Neurophysiology. 556A. Mikami, W. T. Newsome, and R. H. Wurtz, "Motion selectivity in macaque visual cortex. I. Mechanisms of direction and speed selectivity in extrastriate area MT," Journal of Neurophysiology, vol. 55, no. 6, pp. 1308-1327, 1986.</p>
<p>Visual loss and getting lost in Alzheimer's disease. S Tetewsky, C J Duffy, Neurology. 525S. Tetewsky and C. J. Duffy, "Visual loss and getting lost in Alzheimer's disease," Neurology, vol. 52, no. 5, pp. 958-965, 1999.</p>
<p>Visual mechanisms of spatial disorientation in Alzheimer's disease. H L O&apos;brien, S Tetewsky, L M Avery, L A Cushman, W Makous, C J Duffy, Cerebral Cortex. 1111H. L. O'Brien, S. Tetewsky, L. M. Avery, L. A. Cushman, W. Makous, and C. J. Duffy, "Visual mechanisms of spatial disorientation in Alzheimer's disease," Cerebral Cortex, vol. 11, no. 11, pp. 1083-1092, 2001.</p>
<p>The cerebral activity related to the visual perception of forward motion in depth. B M Jong, S Shipp, B Skidmore, R S Frackowiak, S Zeki, Brain. 1175B. M. de Jong, S. Shipp, B. Skidmore, R. S. Frackowiak, and S. Zeki, "The cerebral activity related to the visual perception of forward motion in depth," Brain, vol. 117, no. 5, pp. 1039- 1054, 1994.</p>
<p>Cortical representation of inward and outward radial motion in man. M Ptito, R Kupers, J Faubert, A Gjedde, Neuroimage. 146M. Ptito, R. Kupers, J. Faubert, and A. Gjedde, "Cortical representation of inward and outward radial motion in man," Neuroimage, vol. 14, no. 6, pp. 1409-1415, 2001.</p>
<p>The importance of seeing it coming: a functional magnetic resonance imaging study of motion-in-depth towards the human observer. G Wunderlich, J C Marshall, K Amunts, Neurology Research International. 1123NeuroscienceG. Wunderlich, J. C. Marshall, K. Amunts et al., "The importance of seeing it coming: a functional magnetic resonance imaging study of motion-in-depth towards the human observer," Neuroscience, vol. 112, no. 3, pp. 535-540, 2002. Neurology Research International</p>
<p>Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. B Biswal, F Z Yetkin, V M Haughton, J S Hyde, Magnetic Resonance in Medicine. 344B. Biswal, F. Z. Yetkin, V. M. Haughton, and J. S. Hyde, "Functional connectivity in the motor cortex of resting human brain using echo-planar MRI," Magnetic Resonance in Medicine, vol. 34, no. 4, pp. 537-541, 1995.</p>
<p>Spontaneous activity associated with primary visual cortex: a resting-state fMRI study. K Wang, T Jiang, C Yu, Cerebral Cortex. 183K. Wang, T. Jiang, C. Yu et al., "Spontaneous activity associated with primary visual cortex: a resting-state fMRI study," Cerebral Cortex, vol. 18, no. 3, pp. 697-704, 2008.</p>
<p>The human brain is intrinsically organized into dynamic, anticorrelated functional networks. M D Fox, A Z Snyder, J L Vincent, M Corbetta, D C Van Essen, M E Raichle, Proceedings of the National Academy of Sciences of the United States of America. 10227M. D. Fox, A. Z. Snyder, J. L. Vincent, M. Corbetta, D. C. Van Essen, and M. E. Raichle, "The human brain is intrinsically organized into dynamic, anticorrelated functional networks," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 27, pp. 9673-9678, 2005.</p>
<p>Resting developments: a review of fMRI post-processing methodologies for spontaneous brain activity. D S Margulies, J Böttger, X Long, Biology and Medicine. 235-6Magnetic Resonance Materials in PhysicsD. S. Margulies, J. Böttger, X. Long et al., "Resting develop- ments: a review of fMRI post-processing methodologies for spontaneous brain activity," Magnetic Resonance Materials in Physics, Biology and Medicine, vol. 23, no. 5-6, pp. 289-307, 2010.</p>
<p>Neuronal olscillations in cortical networks. G Buzsáki, A Draguhn, Science. 3045679G. Buzsáki and A. Draguhn, "Neuronal olscillations in cortical networks," Science, vol. 304, no. 5679, pp. 1926-1929, 2004.</p>
<p>Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. M D Fox, M E Raichle, Nature Reviews Neuroscience. 89M. D. Fox and M. E. Raichle, "Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging," Nature Reviews Neuroscience, vol. 8, no. 9, pp. 700- 711, 2007.</p>
<p>Tensorial extensions of independent component analysis for multisubject FMRI analysis. C F Beckmann, S M Smith, Neuroimage. 251C. F. Beckmann and S. M. Smith, "Tensorial extensions of independent component analysis for multisubject FMRI analysis," Neuroimage, vol. 25, no. 1, pp. 294-311, 2005.</p>
<p>Consistent resting-state networks across healthy subjects. J S Damoiseaux, S A Rombouts, F Barkhof, Proceedings of the National Academy of Sciences of the United States of America. the National Academy of Sciences of the United States of America103J. S. Damoiseaux, S. A. Rombouts, F. Barkhof et al., "Consistent resting-state networks across healthy subjects," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 37, pp. 13848-13853, 2006.</p>
<p>fMRI resting state networks define distinct modes of long-distance interactions in the human brain. M De Luca, C F Beckmann, N Stefano, P M Matthews, S M Smith, Neuroimage. 294M. De Luca, C. F. Beckmann, N. De Stefano, P. M. Matthews, and S. M. Smith, "fMRI resting state networks define distinct modes of long-distance interactions in the human brain," Neuroimage, vol. 29, no. 4, pp. 1359-1367, 2006.</p>
<p>Detection of functional connectivity using temporal correlations in MR images. M Hampson, B S Peterson, P Skudlarski, J C Gatenby, J C Gore, Human Brain Mapping. 154M. Hampson, B. S. Peterson, P. Skudlarski, J. C. Gatenby, and J. C. Gore, "Detection of functional connectivity using tem- poral correlations in MR images," Human Brain Mapping, vol. 15, no. 4, pp. 247-262, 2002.</p>
<p>Alzheimer disease: evaluation of a functional MR imaging index as a marker. S J Li, Z Li, G Wu, M J Zhang, M Franczak, P G Antuono, Radiology. 2251S. J. Li, Z. Li, G. Wu, M. J. Zhang, M. Franczak, and P. G. Antuono, "Alzheimer disease: evaluation of a functional MR imaging index as a marker," Radiology, vol. 225, no. 1, pp. 253-259, 2002.</p>
<p>Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI. L Wang, Y Zang, Y He, Neuroimage. 312L. Wang, Y. Zang, Y. He et al., "Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI," Neuroimage, vol. 31, no. 2, pp. 496-504, 2006.</p>
<p>Detection of PCC functional connectivity characteristics in resting-state fMRI in mild Alzheimer's disease. H Y Zhang, S J Wang, J Xing, Behavioural Brain Research. 1971H. Y. Zhang, S. J. Wang, J. Xing et al., "Detection of PCC functional connectivity characteristics in resting-state fMRI in mild Alzheimer's disease," Behavioural Brain Research, vol. 197, no. 1, pp. 103-108, 2009.</p>
<p>Reduced hippocampal functional connectivity in Alzheimer's disease. G Allen, H Barnard, R Mccoll, Archives of Neurology. 6410G. Allen, H. Barnard, R. McColl et al., "Reduced hippocam- pal functional connectivity in Alzheimer's disease," Archives of Neurology, vol. 64, no. 10, pp. 1482-1487, 2007.</p>
<p>Abnormal resting-state functional connectivity of posterior cingulate cortex in amnestic type mild cognitive impairment. F Bai, D R Watson, H Yu, Y Shi, Y Yuan, Z Zhang, Brain Research. 1302F. Bai, D. R. Watson, H. Yu, Y. Shi, Y. Yuan, and Z. Zhang, "Abnormal resting-state functional connectivity of posterior cingulate cortex in amnestic type mild cognitive impairment," Brain Research, vol. 1302, pp. 167-174, 2009.</p>
<p>Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. C Sorg, V Riedl, M Mühlau, Proceedings of the National Academy of Sciences of the United States of America. the National Academy of Sciences of the United States of America104C. Sorg, V. Riedl, M. Mühlau et al., "Selective changes of resting-state networks in individuals at risk for Alzheimer's disease," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 47, pp. 18760-18765, 2007.</p>
<p>Impairment and compensation coexist in amnestic MCI default mode network. Z Qi, X Wu, Z Wang, Neuroimage. 501Z. Qi, X. Wu, Z. Wang et al., "Impairment and compensation coexist in amnestic MCI default mode network," Neuroimage, vol. 50, no. 1, pp. 48-55, 2010.</p>
<p>Network analysis of intrinsic functional brain connectivity in Alzheimer's disease. K Supekar, V Menon, D Rubin, M Musen, M D Greicius, ID e1000100PLoS Computational Biology. 46K. Supekar, V. Menon, D. Rubin, M. Musen, and M. D. Greicius, "Network analysis of intrinsic functional brain connectivity in Alzheimer's disease," PLoS Computational Biology, vol. 4, no. 6, Article ID e1000100, 2008.</p>
<p>Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI. L Wang, Y Zang, Y He, Neuroimage. 312L. Wang, Y. Zang, Y. He et al., "Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI," Neuroimage, vol. 31, no. 2, pp. 496-504, 2006.</p>
<p>Altered functional connectivity in early Alzheimer's disease: a resting-state fMRI study. K Wang, M Liang, L Wang, Human Brain Mapping. 2810K. Wang, M. Liang, L. Wang et al., "Altered functional connectivity in early Alzheimer's disease: a resting-state fMRI study," Human Brain Mapping, vol. 28, no. 10, pp. 967-978, 2007.</p>
<p>Loss of 'small-world' networks in Alzheimer's disease: graph analysis of fMRI resting-state functional connectivity. E J Sanz-Arigita, M M Schoonheim, J S Damoiseaux, ID e13788PLoS One. 511E. J. Sanz-Arigita, M. M. Schoonheim, J. S. Damoiseaux et al., "Loss of 'small-world' networks in Alzheimer's disease: graph analysis of fMRI resting-state functional connectivity," PLoS One, vol. 5, no. 11, Article ID e13788, 2010.</p>
<p>Classification of Alzheimer disease, mild cognitive impairment, and normal cognitive status with large-scale network analysis based on resting-state functional MR imaging. G Chen, B D Ward, C Xie, Radiology. 2591G. Chen, B. D. Ward, C. Xie et al., "Classification of Alzheimer disease, mild cognitive impairment, and normal cognitive status with large-scale network analysis based on resting-state functional MR imaging," Radiology, vol. 259, no. 1, pp. 213-221, 2011.</p>
<p>Resting brain connectivity: changes during the progress of Alzheimer disease. H Y Zhang, S J Wang, B Liu, Radiology. 2562H. Y. Zhang, S. J. Wang, B. Liu et al., "Resting brain connectivity: changes during the progress of Alzheimer disease," Radiology, vol. 256, no. 2, pp. 598-606, 2010.</p>
<p>Motion perception in healthy humans and cognitive disorders," in Early Detection and Rehabilitation Technologies for Dementia: Neuroscience and Biomedical Applications. T Yamasaki, S Tobimatsu, J. WuIGI GlobalPhiladelphia, Pa, USAT. Yamasaki and S. Tobimatsu, "Motion perception in healthy humans and cognitive disorders," in Early Detection and Rehabilitation Technologies for Dementia: Neuroscience and Biomedical Applications, J. Wu, Ed., pp. 156-161, IGI Global, Philadelphia, Pa, USA, 2011.</p>
<p>Electrophysiological evidence for selective impairment of optic flow perception in autism spectrum disorder. T Yamasaki, T Fujita, K Ogata, Research in Autism Spectrum Disorders. 51T. Yamasaki, T. Fujita, K. Ogata et al., "Electrophysiological evidence for selective impairment of optic flow perception in autism spectrum disorder," Research in Autism Spectrum Disorders, vol. 5, no. 1, pp. 400-407, 2011.</p>
<p>An integrated approach to face and motion perception in humans. S Tobimatsu, Y Goto, T Yamasaki, R Tsurusawa, T Taniwaki, Clinical Neurophysiology. 59supplementS. Tobimatsu, Y. Goto, T. Yamasaki, R. Tsurusawa, and T. Taniwaki, "An integrated approach to face and motion perception in humans," Clinical Neurophysiology, vol. 59, supplement, pp. 43-48, 2006.</p>
<p>Non-invasive evaluation of face and motion perception in humans. S Tobimatsu, Y Goto, T Yamasaki, R Tsurusawa, T Taniwaki, Journal of Physiological Anthropology and Applied Human Science. 236S. Tobimatsu, Y. Goto, T. Yamasaki, R. Tsurusawa, and T. Taniwaki, "Non-invasive evaluation of face and motion perception in humans," Journal of Physiological Anthropology and Applied Human Science, vol. 23, no. 6, pp. 273-276, 2004.</p>
<p>Visual ERPs and cortical function. S Tobimatsu, Y Goto, T Yamasaki, T Nakashima, Y Tomoda, A Mitsudome, Progress In Epileptic Disorders. S. Tobimatsu, Y. Goto, T. Yamasaki, T. Nakashima, Y. Tomoda, and A. Mitsudome, "Visual ERPs and cortical function," in Progress In Epileptic Disorders, A. Ikeda and Y.</p>
<p>Event-Related Potentials In Patients With Epilepsy: From Current State To Future Prospects. Inoue, 5Paris, FranceJohn Libbey EurotextInoue, Eds., Vol. 5, Event-Related Potentials In Patients With Epilepsy: From Current State To Future Prospects, pp. 37-48, John Libbey Eurotext, Paris, France, 2008.</p>
<p>A higher order motion region in human inferior parietal lobule: evidence from fMRI. K G Claeys, D T Lindsey, E D Schutter, G A Orban, Neuron. 403K. G. Claeys, D. T. Lindsey, E. D. Schutter, and G. A. Orban, "A higher order motion region in human inferior parietal lobule: evidence from fMRI," Neuron, vol. 40, no. 3, pp. 631- 642, 2003.</p>
<p>Processing 3D form and 3D motion: respective contributions of attention-based and stimulus-driven activity. A L Paradis, J Droulez, V Cornilleau-Pérès, J B Poline, Neuroimage. 434A. L. Paradis, J. Droulez, V. Cornilleau-Pérès, and J. B. Poline, "Processing 3D form and 3D motion: respective con- tributions of attention-based and stimulus-driven activity," Neuroimage, vol. 43, no. 4, pp. 736-747, 2008.</p>
<p>Brain areas sensitive to coherent visual motion. O J Braddick, J M D O&apos;brien, J Wattam-Bell, J Atkinson, T Hartley, Perception. 301O. J. Braddick, J. M. D. O'Brien, J. Wattam-Bell, J. Atkinson, and T. Hartley, "Brain areas sensitive to coherent visual motion," Perception, vol. 30, no. 1, pp. 61-72, 2001.</p>
<p>Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients. M Schroeter, T Stein, N Maslowski, J Neumann, Neuroimage. 474M. Schroeter, T. Stein, N. Maslowski, and J. Neumann, "Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients," Neuroimage, vol. 47, no. 4, pp. 1196-1206, 2009.</p>            </div>
        </div>

    </div>
</body>
</html>